chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient was coming three days late for the third vaccination dose; Case reference number US-BN-2022-003918 is a spontaneous case report initially received from a consumer (reference number: USBAV22-1638) on 06-Oct-2022 and concerns a male patient of unknown age.  The patient's medical history and concomitant medication details were not provided.  On 12-SEP-2022, the patient was vaccinated with the first dose of RabAvert (Rabies Virus (Inactivated, Strain Flury LEP) batch number not provided) at unknow dosage, at an unknown site of administration for post-exposure treatment to rabies and for unknown indication.  On 15-Sep-2022, three days after the first dose, the patient was vaccinated with the second dose of RabAvert (batch number not provided) at unknow dosage, at an unknown site of administration.  On 22-Sep-2022, ten days after the first dose, the patient was vaccinated with the third dose of RabAvert (batch number not provided) at unknow dosage, at an unknown site of administration (explicitly coded as ' Inappropriate schedule of vaccine administered').  At the time of this report, it was unknown whether the patient experienced any adverse events due to RabAvert vaccination, nor if the patient received the fourth dose.  No additional information was provided.  Non-significant case correction performed for information received from Bavarian Nordic on 06-Oct-2022 to include the local case ID.; Reporter's Comments: A male patient of unknown age was vaccinated with the third dose of RabAvert (second dose was administered three days after the first dose) at unknow dosage and site of administration, ten days after the first dose which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown whether the patient experienced any adverse events due to RabAvert vaccination, nor if the patient received the fourth dose. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A male patient of unknown age was vaccinated with the third dose of RabAvert (second dose was administered three days after the first dose) at unknow dosage and site of administration, ten days after the first dose which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown whether the patient experienced any adverse events due to RabAvert vaccination, nor if the patient received the fourth dose. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Systemic: Dizziness / Lightheadness-Mild, Systemic: felt faint hot ,dizzy-Mild, Additional Details: Pt felt faint, hot ,dizzy and a little short of breathe after sitting for 14 min. Gave water, put on fan put pt on floor. Monitored BP and heart rate. Gave water and cookie. Pt said they hadn't had much to drink today. Kept pt 45 min with monitoring. Ca;;ed pt and she is ok now
Fainted, fell to ground, hit her head on floor or table (unsure which).  Stiffening and jerking movements.  Unconscious approx. 30 seconds.
Infection; Bad toothache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TOOTHACHE (Bad toothache) and TOOTH INFECTION (Infection) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced TOOTHACHE (Bad toothache). On an unknown date, the patient experienced TOOTH INFECTION (Infection). At the time of the report, TOOTHACHE (Bad toothache) and TOOTH INFECTION (Infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment details included unspecified Antibiotics.
Coughing/chesty deep coughs/coughs got worse; Chest more painful; cough had  blood in it.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing/chesty deep coughs/coughs got worse), CHEST PAIN (Chest more painful) and HAEMOPTYSIS (cough had  blood in it.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Coughing/chesty deep coughs/coughs got worse), CHEST PAIN (Chest more painful) and HAEMOPTYSIS (cough had  blood in it.). At the time of the report, COUGH (Coughing/chesty deep coughs/coughs got worse), CHEST PAIN (Chest more painful) and HAEMOPTYSIS (cough had  blood in it.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Patient received flu vaccine on 10/3/19, then following day in our office received PCV13 per GI recommendation as he will be starting on a biologic next week. ER was not sure if his symptoms were r/t the vaccine, but mom feels they were. She states they all had dinner on Saturday evening (10/5/19)  (the following day ?) but no one else got sick. Was awoken from sleep ~ 2am on 10/6/19 with projectile vomiting and abdominal pain. Mom states he felt feverish so she took his temp and was 101.2 Continued for about 5 hours with vomiting so mom took him to the ER. They did ABD CT which showed episode was not r/t current Ulcerative Colitis dx, no obstruction etc. ? was given IV fluids, Pepcid, Zofran and Morphine. Vomiting subsided, was able to get some sleep but was awoken again from his sleep in ER with episode of vomiting.  During the day while still at ER, temp spiked up to 103 (around 3pm on 10/6/19) ? discharged later the same day.
Jan 12, injection  Jan 13 Survey?- no symptoms and completed survey Jan 14 early am sore arm and raised knot at injection size of Quarter (showed someone) January 15 mild headache Jan 16 knot at injection site remains.  Congestion. headache. Deep cough use of rescue inhaler Jan 17 addition to symptoms above aches,  chills Jan 18 additional use of rescue inhaler increased deep cough, tired Jan 19 completed survey referencing symptoms. After survey,  said someone would follow up? no f/u to date. Also Left 2 msgs at employee health. worked remotely addition: hoarseness. Knot gone with mild soreness. Cough Jan 20 took sick time. mild headache. hoarseness continues, congestion, tired, cough, Itchiness at injection site * Left Message at Employee Health Jan 21 less aches. Continued cough and rescue inhaler use Jan 22 Nurse from employee Health called back and said they could only document my file and there's nothing they can do. itchiness at injection site. Pat no scratching.  January 23 Asthma attack, tingling at injection site. See pictures below. large raised welt 10:36 p.m. January 24 welt flattening. Looks like ring worm at injection  January 25 flat welt.  redness lighter.  January 26 Slight itchiness at injection site redness lighter and  smaller see picture below. January 23 Image January 23 Image  January 26 Image January 27 Cough, hoarseness continues, sluggish January 28 Made appointment with PCP. Blood work and chest Xray January 29 Cough and hoarseness. Diagnosed asthma/bronchitis.  Prescribe correct inhaler and Zpac
abnormally sever abdominal cramping began afternoon of 4/12/21; felt more painful than appendix bursting (~3/2015); later began menstrual bleeding, despite being on birth control with no expected period for 2 weeks (never spotted/broke through on this form of birth control in ~9 months of taking); had full period over week of 4/12-20/2021 with unusually heaving bleeding, several large clots (~diameter of quarter) and painful cramping
Information has been received from a registered nurse concerning female (age not reported) who on an unspecified date was vaccinated with a first dose of Gardasil (lot# unknown). On an unspecified date the patient was vaccinated with a second dose of Gardasil. Subsequently on an unspecified date the patient developed a rash after the second dose. The chart was not available at the time of the report. At the time of reporting it was unknown if the patient had recovered. No other information was available from the reporter. Additional information has been requested.  01/07/2008 This is in follow-up to report(s) previously submitted on 10/12/2007. Follow-up information was received from a registered nurse. The patient reported that she did not have a reaction to the GARDASIL. The patient's dermatologist was treating her for the problem. Additional information is not expected.
Upper arm red from shoulder to elbow. EXTREMELY painful. Nausea. Muscle pain. I took ibuprofen .  This is the 3rd day and is a little better.
2/23/05 - temp within 8 hours of vaccination. Left leg not moving that much. Moving with pain. Went to ped doctor in am on 2/24/05 was sent to ER. Blood was performed test results - negative. However, pt had increase white blood count 18,000 sent to hospital the same day. Kept for observation 45 hours, sent home on 2/24/05 for bad shot reaction. Motrin and Tylenol prescribed to be administered ever 6 hours prn alternating the meds, by Sunday 2/27/05, pt had no fever and was doing fine.
Left arm became red, swollen, painful, and itchy. Swelling increased for a week. Itching continued for 3 weeks. Pain/tenderness still remains.
This spontaneous report was received from a pharmacist refers to a patient of unknown age. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 04-DEC-2017, the patient was vaccinated with an expired dose of ZOSTAVAX 65 ml, subcutaneously for prophylaxis (lot number M037015, expiration date 22-NOV-2017). The dose of ZOSTAVAX was reconstituted with sterile diluent (MERCK). No adverse effects were reported.
This spontaneous report as received from a nurse practitioner refers to a 19 years old female patient with no medical histories and no drug allergies. On 03-JAN-2013, the patient was vaccinated with a first dose of 0.5 milliliter (ml) of GARDASIL (lot number 669265/0181AA and expiry date 31-JUL-2013)intramuscularly. No concomitant medications were reported. On 06-JAN-2013, the patient was diagnosed with Bells palsy, at an outpatient clinic called Patients First. The outcome of the event was unknown. Additional information has been requested.
Swollen lymph nodes on my neck; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration in Dec2020 at single dose in arm for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the Pfizer Vaccine last Tuesday in Dec2020 and today in Dec2020 the patient woke up with swollen lymph nodes on the neck, opposite side where the arm was injected. The outcome was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Information has been received from a pediatric center concerning a 7 year old male child with no medical history or allergies who on 14-AUG-2000 was vaccinated with varicella virus vaccine live (Oka/Merck). The patient was vaccinated elsewhere. On 09-APR-2007, the patient developed very small papules, 10-20 lesions, some lesions crusted. The patient did not have a fever. The patient is still recovering however, an outcome of recovered on 11-APR-2007 was provided. Medical attention was not sought. Additional information has been requested.
Patient states he was fine for a few days following the vaccine, then on the Tuesday following the vaccine administration he started having "vision problems." He states he "does not feel dizzy but it appears everything is spinning." He said the first morning it happened he almost fell off the bed and has had persistent vision problems since Tuesday.
Acute Pancreatitis; Administration date: 15May2021/Dose number: 1/vaccine date: 15May2021/dose number: 2; This is a spontaneous report from a contactable consumer (patient). This 17-year-old male patient received bnt162b2 (brand: Pfizer), dose 1 via an unspecified route of administration, administered in arm left on 15May2021 17:30 (Batch/Lot Number: EW0182) as dose 1, single at the age of 17-year-old; dose 2 via an unspecified route of administration, administered in arm left on 15May2021 (Batch/Lot Number: EW0179) as dose 2, single at the age of 17-year-old for covid-19 immunisation. No other medical history. No known allergies. No Covid prior vaccination. No Covid tested post vaccination. The patient's concomitant medications were not reported. Facility type vaccine: School or Student Health Clinic. No other vaccine in four weeks. The patient experienced acute pancreatitis on 27Jun2021 03:00. The event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient was hospitalized for acute pancreatitis for 4 days. Therapeutic measures were taken as a result of acute pancreatitis included IV fluids and starvation. The outcome of event acute pancreatitis was not recovered.
Information has been received from a licensed practical nurse concerning a 15 month old male with an amoxicillin allergy who on 04/11/2001 was vaccinated with a first dose of varicella vaccine, SC in left deltoid. On 04/20/2001, the pt developed a temp of 102.3 F and a rash on the body, few dots on chest. On 04/21/2001, the pt developed red dots over the body. In follow-up, the licensed practical nurse stated that the pt "was covered with finish dots all over body." On 04/22/2001, the pt developed three chicken pox like vesicles. In follow-up, the licensed practical nurse stated that the pt had three chickenpox vesicles on the face. On 04/23/2001, the "dots were very faint in color." On 04/24/2001, the licensed practical nurse reported that the areas were fading in color and the child was feeling better. She reported that no treatment or medications were ordered. In follow-up, the licensed practical nurse reported that the pt recovered from his experiences. Unspecified medica attention was sought. No further info is available.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 09-JAN-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route and site of administration were not reported) to obtain permanent prevention and protection against shingles and zoster-related injuries. On an unknown date, after and despite being inoculated with the ZOSTAVAX, the patient was diagnosed with shingles and/or other zoster-related injuries and suffered serious physical, emotional and economic damages as a result of patient's injuries. In 2015, the patient was treated for shingles. The reporter considered adverse events to be related to ZOSTAVAX. As a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care - for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. By the time of the report, the patient did not recover from shingles as the patient suffer for ongoing injuries. The outcome of vaccination failure was unknown. The events were considered to be related to ZOSTAVAX.
This case was reported by a healthcare professional (nurse) and described the occurrence of hbsag positive (hepatitis) in a 57-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medical conditions included diabetes, end stage renal disease and hemodialysis. On 6 July 2012 the subject received 3rd dose of ENGERIX B (40 mcg, intramuscular, left deltoid). The 40 mcg dose was administered as indicated for hemodialysis subject. On 11 July 2012, 5 days after vaccination with ENGERIX B, the subject experienced hbsag positive (hepatitis) ("tested positive for HBsAg"). The healthcare professional stated the test was not done mistakenly, but she suspected the test was false positive result due to vaccine. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the event was unspecified.
10/30/2022 I had a sore throat, weakness, had a low-grade fever and cough.  I felt poorly for about three days. I took an at home COVID test which was positive.  The coughing never fully resolved, and it exacerbated my asthma. I was treating myself at home. So at the end of the November, I saw my doctor and started a new asthma medication, prednisone, antibiotic and a new nasal spray for my asthma. This did not help my asthma. I started another round of antibiotics, prednisone and Trelegy inhaler. In late January I began feeling better. Then in April, 2023, I began feeling bad again and started the antibiotic and prednisone again.
Worsening pain at injection site directly after vaccination and increasing to flu-like symptoms of body aches, fever, head ache, and lethargy.
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    Concurrent medical conditions included Allergy NOS.   On 03-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.            Patient was not  taking any other medications/products within 2 weeks of starting COVID-19 treatment.  It was reported that patient has COVID relapse after Paxlovid..  The device date was reported as 22-May-2022.  Company comment: This spontaneous case concerns a 32-year-old male patient, with no medical history reported, who experienced the non-serious unexpected ADR of COVID-19. The event and vaccination were reported with no onset date; hence the latency of Covid-19 relapse to the third dose of mRNA-1273 vaccine cannot be assessed. No SARS- CoV-2 test was reported. The patient received Paxlovid as a treatment for the event COVID-19. The co-suspect PAXLOVID remains as a confounder for the event. The benefit-risk relationship of the mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 32-year-old male patient, with no medical history reported, who experienced the non-serious unexpected ADR of COVID-19. The event and vaccination were reported with no onset date; hence the latency of Covid-19 relapse to the third dose of mRNA-1273 vaccine cannot be assessed. No SARS- CoV-2 test was reported. The patient received Paxlovid as a treatment for the event COVID-19. The co-suspect PAXLOVID remains as a confounder for the event. The benefit-risk relationship of the mRNA-1273 is not affected by this report.
Patient has myalgia, arthralgia, sore neck, sore throat and joint PLE +CVA tenderness.  Labs U/A positive WBC.  Pt was treated for UTI -> UPRO 500mg BID #20.
Felt lousy and did nothing all day; hives; itching; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt lousy and did nothing all day), URTICARIA (hives), PRURITUS (itching) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt lousy and did nothing all day), URTICARIA (hives), PRURITUS (itching) and PYREXIA (Fever). At the time of the report, MALAISE (Felt lousy and did nothing all day), URTICARIA (hives), PRURITUS (itching) and PYREXIA (Fever) had resolved.            No concomitant medication was reported. The treatment medication was antihistamine. Action taken with m-RNA-1273 in response to the events were not applicable.   This case was linked to MOD-2021-033781, MOD-2021-033781 (Patient Link).
Patient was sitting down about 5 minutes after the shot. He said his vision was almost black and he felt faint.  He requested EMS to be called so I called 911 and ambulance came down. His vision improved alot but he still didn't feel ok so EMS took him to hospital.
extreme lower left abdominal and pelvic pain corresponding with beginning and middle of menstrual cycles and start of IBD-type intestinal pain and constipation.  Patient is self reporting, a biologist, and well read in primary literature surrounding immune responses to covid-19 vaccination.  Patient went to see obgyn at the health center after waiting 14 days after 2nd Pfizer shot, reporting pain and fear that IUD had moved in uterus.  Obgyn performed a transvaginal ultrasound and found that IUD moved lower in uterus and there was a cyst with shadows indicating "blood blistering" in left ovary.  Patient was asked to come back right after next menstrual cycle.  Obgyn removed IUD and removal was extremely painful for patient indicating area around the IUD was inflamed.  Obgyn and Primary care doctor referred patient to a gastroenterologist.  Multiple blood and stool tests were ordered and none explained the pain.  CT scan with contrast was ordered for abdomen and pelvic region.  A left ovarian cyst and fluid in pelvic culdesac was found but radiologist said nothing explained the level of pain being experienced by patient.  Obgyn suggested that patient my have endometriosis (consistent with patient family history).  Patient has been experiencing pelvic pain and IBD symptoms for almost 10 months.   Patient has allergies and also had strong systemic reaction to vaccine starting 12 hours after shot (full body pains, chills, night sweats, fever, headache, extreme fatigue).
Had onset of frontal headache lasting 6 days plus. Was seen in ED. Found to be Hypertensive, despite medication
Systemic: Fainting / Unresponsive-Severe, Additional Details: Pt had an episode of syncope and fell after vaccine administration, 911 was called to evaluate the fall. pt was good and left feeling fine.
Myalgia, Fever, fatigue Narrative:  Per nursing report: "took 2nd dose of Moderna vaccine on Friday morning after getting off work [1/29]. C/o bodyaching, fever, fatigue and  sluggishness on Friday night and Saturday [1/30] and states did not work. States is  feeling much better today."